NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Concentrix Beats on Profit, Misses on Sales and Cuts Outlook

CEO says 50% of revenue now comes from work won since AI rolled out. Margins and cash improved, but traditional work is shrinking.

Concentrix Beats on Profit, Misses on Sales and Cuts Outlook
Credit: Concentrix
Already have an account? Sign in.
09/30/2026 · 6:19 AM
CNXC
/ Don’t stop at just one post.

Related↓

Concentrix Tumbles on Sharp Outlook Cut and Softer Client Demand
06/30/2026 · 7:13 AM

Concentrix Tumbles on Sharp Outlook Cut and Softer Client Demand

Clients are reducing budgets and shifting to cheaper automation.

/ Subscriber only
/ Read more

Feed↓

Mixed Analyst Calls Hit Biotech: Downgrades for Bristol Myers and uniQure, Upgrades for Rezolute and Zentalis
Featured/ 10/05/2026 · 5:30 PM

Mixed Analyst Calls Hit Biotech: Downgrades for Bristol Myers and uniQure, Upgrades for Rezolute and Zentalis

Leerink cut Bristol Myers and raised Zentalis. Barclays lowered uniQure. Cantor upgraded Rezolute. New Buy calls on Ovid, Maravai, and Regenxbio.

/ Subscriber only
Morgan Stanley Says SpaceX Is Cheap Ahead of Flight 15
Featured/ 10/05/2026 · 5:05 PM

Morgan Stanley Says SpaceX Is Cheap Ahead of Flight 15

Morgan Stanley keeps a bullish view on SpaceX, citing growth and a cheaper way into the space and intelligence economy ahead of Flight 15.

/ Subscriber only
McKesson and CD&R close in on buyout of US infusion provider
10/05/2026 · 4:20 PM

McKesson and CD&R close in on buyout of US infusion provider

Option Care Health is in advanced talks on a joint bid from McKesson and CD&R valuing it at more than $5 billion, including debt.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe